Metabolic changes at the early stage of sepsis induced by cecal ligation and puncture in rats and the interventional effects of Huang-Lian-Jie-Du-Tang

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1026, Issue , 2016, Pages 176-182

  Wei, Yufen ^a,c   Gao, Na ^b   Zhang, Zhongxiao ^a   Zu, Xianpeng ^a   Hu, Zhenlin ^a   Zhang, Weidong ^a   Yin, Jun ^b   Liu, Xinru ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Cecal ligation and puncture; Huang Lian Jie Du Tang; Metabolic profiling; Sepsis

Indexed keywords

BIOMARKERS; DIAGNOSIS; DISCRIMINANT ANALYSIS; INDUCTIVELY COUPLED PLASMA; LEAST SQUARES APPROXIMATIONS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETERS; PHYSIOLOGY; RATS; UNSATURATED FATTY ACIDS;

AMINO ACID METABOLISM; CECAL LIGATION AND PUNCTURE; HUANG-LIAN-JIE-DU-TANG; METABOLIC PROFILING; PARTIAL LEAST SQUARES ANALYSIS; PARTIAL LEAST SQUARES DISCRIMINANT ANALYSES (PLSDA); SEPSIS; TIME-OF-FLIGHT MASS SPECTROMETERS;

METABOLISM;

AMINO ACID; BIOLOGICAL MARKER; DRUG METABOLITE; HERBACEOUS AGENT; HUANG LIAN JIE DU TANG; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID; PURINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; CYTOKINE; HUANG-LIEN-CHIEH-TU-TANG;

AMINO ACID METABOLISM; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MALE; METABOLIC REGULATION; METABOLOMICS; NONHUMAN; PARTIAL LEAST SQUARES REGRESSION; PRIORITY JOURNAL; PURINE METABOLISM; QUADRUPOLE MASS SPECTROMETRY; RAT; SEPSIS; SURVIVAL RATE; ANIMAL; BLOOD; CECUM; MASS SPECTROMETRY; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CECUM; CHROMATOGRAPHY, LIQUID; CYTOKINES; DRUGS, CHINESE HERBAL; MALE; MASS SPECTROMETRY; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; SURVIVAL RATE;

EID: 84941286867     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2015.08.009     Document Type: Article

References (44)

1. [1] Lever, A., Mackenzie, I., Sepsis: definition, epidemiology, and diagnosis. Br. Med. J. 335 (2007), 879–883.
2. [2] Levy, M.M., Fink, M.P., Marshall, J.C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S.M., Vincent, J.-L., Ramsay, G., 2001 sccm/esicm/accp/ats/sis international sepsis definitions conference. Intensive Care Med. 29 (2003), 530–538.
3. [3] Wheeler, A.P., Bernard, G.R., Treating patients with severe sepsis. N. Engl. J. Med. 340 (1999), 207–214.
4. [4] Hotchkiss, R.S., Karl, I.E., The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348 (2003), 138–150.
5. [5] Russell, J.A., Management of sepsis. N. Engl. J. Med. 355 (2006), 1699–1713.
6. [6] Okazaki, Y., Matsukawa, A., Pathophysiology of sepsis and recent patents on the diagnosis, treatment and prophylaxis for sepsis. Recent Patents Inflamm. Allergy Drug Discovery 3 (2009), 26–32.
7. [7] Dellinger, R.P., Levy, M.M., Carlet, J.M., Bion, J., Parker, M.M., Jaeschke, R., Reinhart, K., Angus, D.C., Brun-Buisson, C., Beale, R., Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 34 (2008), 17–60.
8. [8] Nicholson, J.K., Lindon, J.C., Systems biology: metabonomics. Nature 455 (2008), 1054–1056.
9. [9] Weckwerth, W., Morgenthal, K., Metabolomics: from pattern recognition to biological interpretation. Drug Discovery Today 10 (2005), 1551–1558.
10. [10] Trifonova, O., Lokhov, P., Archakov, A., Postgenomics diagnostics: metabolomics approaches to human blood profiling. OMICS 17 (2013), 550–559.
11. [11] Gomez-Casati, D.F., Zanor, M.I., Busi, M.V., Metabolomics in plants and humans: applications in the prevention and diagnosis of diseases. BioMed Res. Int., 2013, 2013, 792527.
12. [12] Seymour, C.W., Yende, S., Scott, M.J., Pribis, J., Mohney, R.P., Bell, L.N., Chen, Y.F., Zuckerbraun, B.S., Bigbee, W.L., Yealy, D.M., Weissfeld, L., Kellum, J.A., Angus, D.C., Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study. Intensive Care Med. 39 (2013), 1423–1434.
13. [13] Van Cromphaut, S.J., Vanhorebeek, I., Van den Berghe, G., Glucose metabolism and insulin resistance in sepsis. Curr. Pharm. Des. 14 (2008), 1887–1899.
14. [14] Cao, Y., Gao, C., Sun, J., Wang, J., Zhou, Q., Liu, G., Study on pharmacological effects of huanglianjiedu tang extract. J. China Pharm. Univ. 27 (1996), 605–608.
15. [15] Wei, Y., Shan, L., Qiao, L., Liu, R., Hu, Z., Zhang, W., Protective effects of Huang-Lian-Jie-Du-Tang against polymicrobial sepsis induced by cecal ligation and puncture in rats. Evidence Based Complement. Altern. Med., 2013, 2013, 909624.
16. [16] Zeng, H., Liu, X., Dou, S., Xu, W., Li, N., Liu, X., Zhang, W., Hu, Z., Liu, R., Huang-Lian-Jie-Du-Tang exerts anti-inflammatory effects in rats through inhibition of nitric oxide production and eicosanoid biosynthesis via the lipoxygenase pathway. J. Pharm. Pharmacol. 61 (2009), 1699–1707.
17. [17] Dou, S., Liu, L., Jiang, P., Zhang, W., Liu, R., LC–DAD and LC–ESI–MS chromatographic fingerprinting and quantitative analysis for evaluation of the quality of Huang-Lian-Jie-Du-Tang. Chromatographia 69 (2009), 659–664.
18. [18] Şener, G., Toklu, H., Ercan, F., Erkanlı, G., Protective effect of β-glucan against oxidative organ injury in a rat model of sepsis. Int. Immunopharmacol. 5 (2005), 1387–1396.
19. [19] Ritter, C., Andrades, M., Frota, M.L.C. Jr., Bonatto, F., Pinho, R.A., Polydoro, M., Klamt, F., Pinheiro, C.T., Menna-Barreto, S.S., Moreira, J.C.F., Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med. 29 (2003), 1782–1789.
20. [20] Dunn, W.B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J.D., Halsall, A., Haselden, J.N., Nicholls, A.W., Wilson, I.D., Kell, D.B., Goodacre, R., Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6 (2011), 1060–1083.
21. [21] Chadeau-Hyam, M., Ebbels, T.M., Brown, I.J., Chan, Q., Stamler, J., Huang, C.C., Daviglus, M.L., Ueshima, H., Zhao, L., Holmes, E., Nicholson, J.K., Elliott, P., De Iorio, M., Metabolic profiling and the metabolome-wide association study: significance level for biomarker identification. J. Proteome Res. 9 (2010), 4620–4627.
22. [22] Jiang, P., Dai, W., Yan, S., Chen, Z., Xu, R., Ding, J., Xiang, L., Wang, S., Liu, R., Zhang, W., Potential biomarkers in the urine of myocardial infarction rats: a metabolomic method and its application. Mol. Biosyst. 7 (2011), 824–831.
23. [23] Chen, J., Wang, W., Lv, S., Yin, P., Zhao, X., Lu, X., Zhang, F., Xu, G., Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Anal. Chim. Acta 650 (2009), 3–9.
24. [24] Wiklund, S., Johansson, E., Sjostrom, L., Mellerowicz, E.J., Edlund, U., Shockcor, J.P., Gottfries, J., Moritz, T., Trygg, J., Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal. Chem. 80 (2008), 115–122.
25. [25] Hack, C.E., Aarden, L.A., Thus, L.G., Role of cytokines in sepsis. Adv. Immunol. 66 (1997), 101–195.
26. [26] Adib-Conquy, M., Cavaillon, J.M., Host inflammatory and anti-inflammatory response during sepsis. Pathol. Biol. (Paris) 60 (2012), 306–313.
27. [27] Zhang, H., Fu, P., Ke, B., Wang, S., Li, M., Han, L., et al. Metabolomic analysis of biochemical changes in the plasma and urine of collagen-induced arthritis in rats after treatment with Huang-Lian-Jie-Du-Tang. J. Ethnopharmacol. 154 (2014), 55–64.
28. [28] Yue, R., Zhao, L., Hu, Y., Jiang, P., Wang, S., Xiang, L., et al. Metabolomic study of collagen-induced arthritis in rats and the interventional effects of Huang-Lian-Jie-Du-Tang, a traditional Chinese medicine. Evidence Based Complement. Altern. Med., 2013, 2013, 439690.
29. [29] de Jong, H.K., van der Poll, T., Wiersinga, W.J., The systemic pro-inflammatory response in sepsis. J. Innate Immun. 2 (2010), 422–430.
30. [30] Meijers, B.K., De Loor, H., Bammens, B., Verbeke, K., Vanrenterghem, Y., Evenepoel, P., p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 4 (2009), 1932–1938.
31. [31] Mitsuda, H., Yuasumoto, K., Iwami, K., Antioxidation action of indole compounds during the autoxidation of linoleic acid. Eiyo to Shokuryo 19 (1996), 210–214.
32. [32] Ikeda, M., Ohtsuji, H., Significance of urinary hippuric acid determination as an index of toluene exposure. Br. J. Ind. Med. 26 (1969), 244–246.
33. [33] Bodel, P., Cotran, R., Kass, E., Cranberry juice and the antibacterial action of hippuric acid. J. Lab. Clin. Med. 54 (1959), 881–888.
34. [34] Abbas, S.Y., El-Sharief, M.A., Basyouni, W.M., Fakhr, I.M., El-Gammal, E.W., Thiourea derivatives incorporating a hippuric acid moiety: synthesis and evaluation of antibacterial and antifungal activities. Eur. J. Med. Chem. 64 (2013), 111–120.
35. [35] Chioléro, R., Revelly, J.-P., Tappy, L., Energy metabolism in sepsis and injury. Nutrition 13 (1997), 45–51.
36. [36] Martinez, A., Chiolero, R., Bollman, M., Revelly, J.P., Berger, M., Cayeux, C., Tappy, L., Assessment of adipose tissue metabolism by means of subcutaneous microdialysis in patients with sepsis or circulatory failure. Clin. Physiol. Funct. Imaging 23 (2003), 286–292.
37. [37] Eaton, S., Pierro, A., Carnitine and fatty acid oxidation in sepsis. Monatsh. Chem. 136 (2005), 1483–1492.
38. [38] Lanza-Jacoby, S., Holahan, M., Reibel, D.K., Changes in tissue levels of carnitine during E. coli sepsis in the rat. Circ. Shock 24 (1988), 29–34.
39. [39] Calder, P.C., Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?. Br. J. Clin. Pharmacol. 75 (2013), 645–662.
40. [40] Bruegel, M., Ludwig, U., Kleinhempel, A., Petros, S., Kortz, L., Ceglarek, U., Holdt, L.M., Thiery, J., Fiedler, G.M., Sepsis-associated changes of the arachidonic acid metabolism and their diagnostic potential in septic patients. Crit. Care Med. 40 (2012), 1478–1486.
41. [41] Tsutsumi, R., Horikawa, Y.T., Kume, K., Tanaka, K., Kasai, A., Kadota, T., Tsutsumi, Y.M., Whey peptide-based formulas with omega-3 fatty acids are protective in LPS-mediated sepsis. JPEN J. Parenter. Enteral. Nutr. 39:5 (2015), 552–561.
42. [42] Pontes-Arruda, A., Martins, L.F., de Lima, S.M., Isola, A.M., Toledo, D., Rezende, E., Maia, M., Magnan, G.B., Investigating Nutritional Therapy with EPA, GLA and Antioxidants Role in Sepsis Treatment (INTERSEPT) Study Group. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT study. Crit. Care, 15, 2011, R144.
43. [43] Grau-Carmona, T., Moran-Garcia, V., Garcia-de-Lorenzo, A., Heras-de-la-Calle, G., Quesada-Bellver, B., Lopez-Martinez, J., Gonzalez-Fernandez, C., Montejo-Gonzalez, J.C., Blesa-Malpica, A., Albert-Bonamusa, I., Bonet-Saris, A., Herrero-Meseguer, J.I., Mesejo, A., Acosta, J., Effect of an enteral diet enriched with eicosapentaenoic acid, gamma-linolenic acid and anti-oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clin. Nutr. 30 (2011), 578–584.
44. [44] Calder, P.C., A novel effect of eicosapentaenoic acid: improved diaphragm strength in endotoxemia. Crit. Care, 14, 2010, 143.